,,iv #aaf? ,,congress #b;d ,session ,h4 ,,res4 #ihj ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,may #bf1 #bjbj,mr4 ,quigley submitt$ ! foll[+ resolution2 :i* 0 ref]r$ to ! ,committee on ,en]gy & ,comm]ce ,,resolution ,express+ support = designation ( ,may #bjbj z ,national ,bra9 ,tumor ,aw>5ess ,mon?4 ,:]eas m ?an #hf1jjj p 9 ! ,unit$ ,/ates 7 diagnos$ ) a prim>y bra9 tumor la/ ye>1 & an e/imat$ #hg1bdj ,am]icans w receive a prim>y bra9 tumor diagnosis 9 #bjbj2 ,:]eas bra9 tumors are ! lead+ cause ( dea? f canc] 9 *ildr5 "u ! age ( #ad1 ! lead+ cause ( dea? f canc] = te5s "u ! age ( #ai1 & ?ird lead+ cause ( dea? f canc] 9 "y adults ages #bj to #ci2 ,:]eas ! five-ye> relative survival rate 9 ! ,unit$ ,/ates foll[+ diagnosis ( a prim>y malignant bra9 & sp9al tumor is only #cf p]c5t2 ,:]eas ov] #ah1jjj p 9 ! ,unit$ ,/ates lo/ _! battle ) a bra9 tumor la/ ye>2 ,:]eas bra9 tumors may be ei!r malignant or b5ign1 b c be life-?reat5+ 9 ei!r case2 ,:]eas an e/imat$ #gjj1jjj p 9 ! ,unit$ ,/ates are curr5tly liv+ ) a bra9 tumor2 ,:]eas treatm5t ( bra9 tumors is complicat$ by ! fact t !re are m ?an #acj diff]5t types ( tumors2 ,:]eas ! treatm5t & removal ( bra9 tumors pres5t significant *all5ges because ( ! bra9's uniquely complex & fragile nature2 ,:]eas bra9 tumors affect ! prim>y organ 9 ! human body t n only controls cognitive ability1 b ! actions ( e o!r organ & limb 9 ! body1 lead+ to x be+ describ$ z a disease t affects ! ess5ce ( self2 ,:]eas ! fir/ resolution recogniz+ ! ne$ = a ,national ,bra9 ,tumor ,aw>5ess ,mon? 0 pass$ by ! ,h\se ( ,repres5tatives on ,may #ba1 #bjjh2 ,:]eas bra9 tumor rese>* is support$ by a numb] ( private nonpr(it rese>* f\ndations & by in/itutes at ! ,national ,in/itutes ( ,heal?1 includ+ ! ,national ,canc] ,in/itute & ,national ,in/itute = ,neurological ,disord]s & ,/roke2 ,:]eas basic rese>* advances may fuel rese>* & developm5t ( new treatm5ts2 ,:]eas !re /ill rema9 daunt+ ob/acles to ! developm5t ( new treatm5ts & !re are no /rategies = scre5+ or e>ly detection ( bra9 tumors2 ,:]eas despite ! numb] ( new p diagnos$ ) a bra9 tumor e ye>1 & _! deva/at+ prognosis1 !re h only be5 five ,food & ,drug ,adm9i/ration-approv$ drugs & "o device to treat bra9 tumors 9 ! pa/ #cj ye>s2 ,:]eas ! five approv$ drugs = bra9 tumors h provid$ only increm5tal improvem5ts to pati5t survival1 & mortality rates rema9 little *ang$ ov] ! pa/ #cj ye>s2 ,:]eas !re is a ne$ = great] public aw>5ess ( bra9 tumors1 includ+ ! difficulties associat$ ) rese>* on ^! tumors & ! opportunities = advances 9 bra9 tumor rese>* & treatm5t2 & ,:]eas ,may #bjbj1 :5 bra9 tumor advocates nationwide unite 9 aw>5ess1 outrea*1 & advocacy activities1 w\ld be an appropriate mon? to recognize z ,national ,bra9 ,tumor ,aw>5ess ,mon?3 ,n[1 !re=e1 be x ,t ! ,h\se ( ,repres5tatives-- 7#a7 supports ! designation ( ,national ,bra9 ,tumor ,aw>5ess ,mon?2 7#b7 enc\rages increas$ public aw>5ess ( bra9 tumors to honor ^? :o h lo/ _! lives to ?is deva/at+ disease or are curr5tly liv+ ) a bra9 tumor diagnosis2 7#c7 supports ef=ts to develop bett] treatm5ts = bra9 tumors t w improve ! quality ( life & ! long-t]m prognosis ( ^? individuals diagnos$ ) a bra9 tumor2 7#d7 expresses its support = ^? individuals :o are battl+ bra9 tumors1 z well z ! families1 fri5ds1 & c>egiv]s ( ^? individuals2 & 7#e7 urges t a collaborative public-private approa* to bra9 tumor rese>* is ! be/ means ( advanc+ k ( & treatm5t = ! disease4